Skip to main content

Table 4 Statistical comparison for 20 post-treatment dosimetries regarding tumor dose, non-tumoral liver (NTL) dose, tumor fraction receiving at least 150 Gy, and non-tumoral liver (NTL) fraction receiving between 0 and 50 Gy

From: Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using 166Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging

Criteria

DEW [mean ± std dev]

TEW [mean ± std dev]

p-val

Tumor dose

178.95 ± 63.82 Gy

168.30 ± 64.13 Gy

0.04*

NTL dose

34.90 ± 20.70 Gy

35.20 ± 21.06 Gy

0.59

 ≥ 150 Gy tumor fraction

57.61 ± 29.60%

50.88 ± 31.11%

0.07

0–50 Gy NTL fraction

75.95 ± 17.78%

73.64 ± 17.93%

0.04*

  1. p-values (p-val) are obtained from paired t-test analysis and considered significant if ≤ 0.05 (*)